SEC Form 4 · accession 0001179110-18-003300
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon J Bracken
Officer — Senior Vice President
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 5:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Feb 28, 2018 | F | 2,056 | $60.55 | D | 47,443 | D | |
| Common shares without par value | Mar 1, 2018 | S | 1,053 | $58.9325 | D | 46,390 | D | |
| Common shares without par valueF1 | holding | — | — | — | 747 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2018.
Remarks
The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).